Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology

Margaret A. Tempero; Stephen Behrman; Edgar Ben-Josef; Al B. Benson; John L. Cameron; Ephraim S. Casper; John P. Hoffman; Richard C. Karl; Paula Kim; Wui Jin Koh; Boris W. Kuvshinoff; W. Scott Melvin; Peter Muscarella; Aaron R. Sasson; Stephen Shibata; Dennis C. Shrieve; Mark S. Talamonti; Douglas S. Tyler; Selwyn M. Vickers; Robert S. Warren; Christopher Willett; Robert A. Wolff

doi:10.6004/jnccn.2005.0035

Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology

Margaret A. Tempero
, Stephen Behrman
, Edgar Ben-Josef
, Al B. Benson
, John L. Cameron
, Ephraim S. Casper
, John P. Hoffman
, Richard C. Karl
, Paula Kim
, Wui Jin Koh
, Boris W. Kuvshinoff
, W. Scott Melvin
, Peter Muscarella
, Aaron R. Sasson
, Stephen Shibata
, Dennis C. Shrieve
, Mark S. Talamonti
, Douglas S. Tyler
, Selwyn M. Vickers
, Robert S. Warren

Christopher Willett, Robert A. Wolff

University of California at San Francisco
University of Tennessee Cancer Institute
University of Michigan, Ann Arbor
Northwestern University
Johns Hopkins University
Memorial Sloan-Kettering Cancer Center
Fox Chase Cancer Center
Moffitt Cancer Center
Pancreatic Cancer Action Network
Seattle Cancer Care Alliance
Roswell Park Cancer Institute
Ohio State University
City of Hope Cancer Center
University of Utah
Duke University
University of Alabama at Birmingham
University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Review article › peer-review

41 Scopus citations

Abstract

Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the NCCN Panel recommends that investigational options be considered in all phases of disease management. For patients with advanced disease, supportive care may be considered in accordance with the NCCN Palliative Care Guidelines (for the most up-to-date version of this and other guidelines, please visit http://www.nccn.org).

Original language	English
Pages (from-to)	598-626
Number of pages	29
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	3
Issue number	5
DOIs	https://doi.org/10.6004/jnccn.2005.0035
State	Published - Sep 2005

Keywords

Adenocarcinoma
Ductal carcinoma
Endoscopic retrograde cholangiopancreatography
Gemcitabine
NCCN Clinical Practice Guidelines
Pancreas
Ultrasonography

Access to Document

10.6004/jnccn.2005.0035

Cite this

Tempero, M. A., Behrman, S., Ben-Josef, E., Benson, A. B., Cameron, J. L., Casper, E. S., Hoffman, J. P., Karl, R. C., Kim, P., Koh, W. J., Kuvshinoff, B. W., Melvin, W. S., Muscarella, P., Sasson, A. R., Shibata, S., Shrieve, D. C., Talamonti, M. S., Tyler, D. S., Vickers, S. M., ... Wolff, R. A. (2005). Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network, 3(5), 598-626. https://doi.org/10.6004/jnccn.2005.0035

@article{1be0014bb710421ea1f2a111395cb5a2,

title = "Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology",

abstract = "Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the NCCN Panel recommends that investigational options be considered in all phases of disease management. For patients with advanced disease, supportive care may be considered in accordance with the NCCN Palliative Care Guidelines (for the most up-to-date version of this and other guidelines, please visit http://www.nccn.org).",

keywords = "Adenocarcinoma, Ductal carcinoma, Endoscopic retrograde cholangiopancreatography, Gemcitabine, NCCN Clinical Practice Guidelines, Pancreas, Ultrasonography",

author = "Tempero, \{Margaret A.\} and Stephen Behrman and Edgar Ben-Josef and Benson, \{Al B.\} and Cameron, \{John L.\} and Casper, \{Ephraim S.\} and Hoffman, \{John P.\} and Karl, \{Richard C.\} and Paula Kim and Koh, \{Wui Jin\} and Kuvshinoff, \{Boris W.\} and Melvin, \{W. Scott\} and Peter Muscarella and Sasson, \{Aaron R.\} and Stephen Shibata and Shrieve, \{Dennis C.\} and Talamonti, \{Mark S.\} and Tyler, \{Douglas S.\} and Vickers, \{Selwyn M.\} and Warren, \{Robert S.\} and Christopher Willett and Wolff, \{Robert A.\}",

year = "2005",

month = sep,

doi = "10.6004/jnccn.2005.0035",

language = "English",

volume = "3",

pages = "598--626",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "5",

}

Tempero, MA, Behrman, S, Ben-Josef, E, Benson, AB, Cameron, JL, Casper, ES, Hoffman, JP, Karl, RC, Kim, P, Koh, WJ, Kuvshinoff, BW, Melvin, WS, Muscarella, P, Sasson, AR, Shibata, S, Shrieve, DC, Talamonti, MS, Tyler, DS, Vickers, SM, Warren, RS, Willett, C & Wolff, RA 2005, 'Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 3, no. 5, pp. 598-626. https://doi.org/10.6004/jnccn.2005.0035

TY - JOUR

T1 - Pancreatic adenocarcinoma

T2 - Clinical Practice Guidelines in Oncology

AU - Tempero, Margaret A.

AU - Behrman, Stephen

AU - Ben-Josef, Edgar

AU - Benson, Al B.

AU - Cameron, John L.

AU - Casper, Ephraim S.

AU - Hoffman, John P.

AU - Karl, Richard C.

AU - Kim, Paula

AU - Koh, Wui Jin

AU - Kuvshinoff, Boris W.

AU - Melvin, W. Scott

AU - Muscarella, Peter

AU - Sasson, Aaron R.

AU - Shibata, Stephen

AU - Shrieve, Dennis C.

AU - Talamonti, Mark S.

AU - Tyler, Douglas S.

AU - Vickers, Selwyn M.

AU - Warren, Robert S.

AU - Willett, Christopher

AU - Wolff, Robert A.

PY - 2005/9

Y1 - 2005/9

N2 - Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the NCCN Panel recommends that investigational options be considered in all phases of disease management. For patients with advanced disease, supportive care may be considered in accordance with the NCCN Palliative Care Guidelines (for the most up-to-date version of this and other guidelines, please visit http://www.nccn.org).

AB - Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the NCCN Panel recommends that investigational options be considered in all phases of disease management. For patients with advanced disease, supportive care may be considered in accordance with the NCCN Palliative Care Guidelines (for the most up-to-date version of this and other guidelines, please visit http://www.nccn.org).

KW - Adenocarcinoma

KW - Ductal carcinoma

KW - Endoscopic retrograde cholangiopancreatography

KW - Gemcitabine

KW - NCCN Clinical Practice Guidelines

KW - Pancreas

KW - Ultrasonography

UR - https://www.scopus.com/pages/publications/33644690815

U2 - 10.6004/jnccn.2005.0035

DO - 10.6004/jnccn.2005.0035

M3 - Review article

C2 - 16194453

AN - SCOPUS:33644690815

SN - 1540-1405

VL - 3

SP - 598

EP - 626

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 5

ER -

Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this